Kyra et al. found that myelin basic protein (MBP) antibody titer was the only independent predictor of cognitive decline after stroke by evaluating the Mini-Mental State Examination (MMSE) scores and autoantibody levels in post-stroke patients (Becker et al., 2016). This evidence concerns the gene MBP and stroke disorder.